SCHEMBL7740374

SCHEMBL7740374

CCCCc1n[nH]c2ccc(C)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
MAP2K4 P45985 9/20 0.47
MAPK1 P28482 5/20 0.45
MAPKAPK3 Q16644 5/20 0.45
MAPK6 Q16659 5/20 0.45
MAPKAPK2 P49137 4/20 0.45
MAPKAPK5 Q8IW41 3/20 0.45
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ITK Q08881 2/20 0.42
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
UTS2R Q9UKP6 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
FADS1 O60427 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20001489 0.90 MAP2K4 (0.48) MAPTHTTMAP2K4MAPK1MAPKAPK3
SCHEMBL7352631 0.83 MAP2K4 (0.50) MAPTMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL7740372 0.83 HSP90AA1 (0.37) MAPTHTTMAP2K4MAPK1TSHR
SCHEMBL27750994 0.82 MAP2K4 (0.54) MAPTMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL15826217 0.79 HTR1A (0.48) MAPTHSD17B10KDM4EALDH1A1ACHE
SCHEMBL7134511 0.78 CYP3A4 (0.44) MAPTHTTMAP2K4MAPK1MAPKAPK3
SCHEMBL22632566 0.78 PDPK1 (0.50) FADS1
SCHEMBL5952447 0.78 MAP2K4 (0.60) MAPTMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL1326632 0.78 KDM4E (0.46) HTTTSHRHSD17B10KDM4EGAA
SCHEMBL24025971 0.76 HTR1A (0.38) MAPTTSHRHSD17B10KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37781-E1 VIRICIDES, PROTEASE INHIBITOR DUPONT PHARMACEUTICALS COMPANY 2002-07-02 US claimed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US claimed